Identification of Synergistic Drug Combinations Using Breast Cancer Patient-Derived Xenografts

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-58438-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patient-Derived Breast Tumor Xenografts Facilitating Personalized Cancer Therapy

Breast Cancer Research
Cancer ResearchOncology
2013English

In-Silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-Omics Data

Scientific Reports
Multidisciplinary
2019English

Nanomedicine of Synergistic Drug Combinations for Cancer Therapy – Strategies and Perspectives

Journal of Controlled Release
Pharmaceutical Science
2016English

P1.04-08 Co-Residence of Patient-Derived Immune Cells in Patient-Derived Xenografts From Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Establishment of Patient-Derived Xenografts in Mice

BIO-PROTOCOL
2016English

A Computational Approach for Identifying Synergistic Drug Combinations

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2017English

Gene Expression Differences Between Matched Pairs of Ovarian Cancer Patient Tumors and Patient-Derived Xenografts

Scientific Reports
Multidisciplinary
2019English

Measuring Human Carboxylesterase 2 Activity in Pancreatic Cancer Patient-Derived Xenografts Using a Ratiometric Fluorescent Chemosensor

Chemical Science
Chemistry
2019English

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison With Patient Clinical Data

Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy